SCYNEXIS, Inc. (SCYX)
5.15
-0.15
(-2.83%)
USD |
NASDAQ |
Sep 08, 16:00
SCYNEXIS Total Liabilities (Quarterly) : 8.04M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.04M |
| March 31, 2026 | 36.32M |
| December 31, 2025 | 9.651M |
| September 30, 2025 | 14.64M |
| June 30, 2025 | 16.23M |
| March 31, 2025 | 17.38M |
| December 31, 2024 | 35.57M |
| September 30, 2024 | 40.51M |
| June 30, 2024 | 47.40M |
| March 31, 2024 | 44.15M |
| December 31, 2023 | 55.45M |
| September 30, 2023 | 56.56M |
| June 30, 2023 | 61.78M |
| March 31, 2023 | 100.21M |
| December 31, 2022 | 84.58M |
| September 30, 2022 | 95.08M |
| June 30, 2022 | 90.13M |
| March 31, 2022 | 72.64M |
| December 31, 2021 | 78.58M |
| September 30, 2021 | 72.27M |
| June 30, 2021 | 88.81M |
| March 31, 2021 | 74.15M |
| December 31, 2020 | 79.78M |
| September 30, 2020 | 27.19M |
| June 30, 2020 | 38.93M |
| Date | Value |
|---|---|
| March 31, 2020 | 35.05M |
| December 31, 2019 | 44.26M |
| September 30, 2019 | 27.67M |
| June 30, 2019 | 30.67M |
| March 31, 2019 | 33.74M |
| December 31, 2018 | 21.94M |
| September 30, 2018 | 23.77M |
| June 30, 2018 | 31.50M |
| March 31, 2018 | 28.64M |
| December 31, 2017 | 24.44M |
| September 30, 2017 | 22.36M |
| June 30, 2017 | 20.18M |
| March 31, 2017 | 23.12M |
| December 31, 2016 | 24.97M |
| September 30, 2016 | 27.84M |
| June 30, 2016 | 9.649M |
| March 31, 2016 | 5.637M |
| December 31, 2015 | 7.324M |
| September 30, 2015 | 6.125M |
| June 30, 2015 | 7.906M |
| March 31, 2015 | 7.419M |
| December 31, 2014 | 6.241M |
| September 30, 2014 | 5.822M |
| June 30, 2014 | 6.536M |
| March 31, 2014 | 33.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.97M |
| Shareholders Equity (Quarterly) | 66.93M |
| Debt to Equity Ratio | 0.0291 |
| Current Ratio | 9.563 |
| Net Debt Paydown Yield | 0.27% |